{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"358"},{"groupId":"OG001","value":"354"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3789"},{"groupId":"OG001","value":"3787"}],"units":"Participants"}],"description":"Clinical fracture at any time, including hip, spine, wrist fractures and other bone fractures.","groups":[{"description":"Patients receive oral exemestane (25 mg) once daily for 5 years.\n\nexemestane: Given orally","id":"OG000","title":"Exemestane"},{"description":"Patients receive oral anastrozole (1 mg) once daily for 5 years.\n\nanastrozole: Given orally","id":"OG001","title":"Anastrozole"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"8 years","title":"Clinical Fracture Rate: Number of Participants With Bone Fractures.","type":"SECONDARY","unitOfMeasure":"Participants"}